The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
Cancer blockbuster Revlimid has been suffering from generic competition, while Eliquis will be one of the first drugs to face ...
The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name ...
The anticlotting drug, Eliquis, has been approved for use in the United States by the country’s regulatory body, the Food and Drug Administration (FDA). Eliquis is manufactured by Bristol-Myers ...
The increase came from Eliquis and the company's so-called Growth Portfolio of drugs, which includes a ... which is facing generic competition due to its loss of exclusivity.
The first session, on Eliquis, is set for Oct. 30 ... negotiate prices of certain high-expenditure, single-source drugs without generic or biosimilar competition. "Today is the start of a new ...